Expert Insights for Health Science Companies

As a global leader in health science M&A, recapitalization, and growth financing strategies, Crosstree has led 100+ transactions for companies at the center of this fast-moving industry.

Resource

Innovations in Pharmaceutical Development™
Crosstree’s in-depth guide to the most innovative people, companies, and solutions in pharma services.

February 8, 2021

Introducing Innovations in Pharmaceutical Development™ In this first-of-its-kind book, Crosstree profiles over 50 of the most innovative companies and thought…

Read Resource
Video

How Innovations across Pharma Development Delivered the COVID-19 Vaccine with Rick Cimino

February 5, 2021

Rick Cimino of TwoLabs and Evolution Research Group and independent panelist for Crosstree’s Innovations in Pharmaceutical Development discusses how innovation...

Video

Innovation’s Role in Life Sciences with Rick Riegel

February 5, 2021

Rick Riegel of LMC Advisory and independent panelist for Crosstree’s Innovations in Pharmaceutical Development, discusses the role of innovation in...

Video

COVID-19 Impact on Pharma Development Innovation with Steve Sullivan

February 5, 2021

Steve Sullivan of CRO Advisors and independent panelist for Crosstree’s Innovations in Pharmaceutical Development discusses how COVID-19 has accelerated innovation...

Video

Global Connectivity and Pharma Development Innovation with Steve Gens

February 5, 2021

Steve Gens of Gens and Associates, one of nine top innovative Thought Leaders profiled in Crosstree’s Innovations in Pharmaceutical Development™,...

View All

We were impressed with the intensity and thoroughness of Crosstree’s preparation. Their team worked tirelessly on analytics and positioning, ultimately giving us the flexibility to efficiently navigate various strategic options involving our business and each of its two divisions. I wouldn’t think twice about using Crosstree again.

Crosstree did an exceptional job with our process. We benefited greatly from their industry knowledge, expansive network, deal expertise and just plain hard work. Most importantly, their bankers demonstrated sterling integrity and always gave us sound advice that resulted in an excellent outcome, despite numerous twists and turns along the way.

Crosstree’s specific knowledge of our market segment allowed them to precisely target potential buyers. Further, Crosstree guided management to the right “value drivers” for each potential buyer, optimally tuning our various presentations, and ultimately driving enhanced valuations during the auction process.

Explore greater market insights and financial possibilities with the leading experts in health science.

Jeff Ellis

Jeff Ellis

Co-Founder & Managing Director
Shane Senior, CFA

Shane Senior, CFA

Co-Founder & Managing Director
Frederic Laurier

Frederic Laurier

Managing Director
Zeke Navar

Zeke Navar

Managing Director
Rusty Ray

Rusty Ray

Managing Director
Gordon Ryerson

Gordon Ryerson

Managing Director
Lance Converse

Lance Converse

Managing Partner - Crosstree Equity Fund
Roman Margolin

Roman Margolin

Managing Partner - Crosstree Equity Fund
Christian Carlson, PhD

Christian Carlson, PhD

Director
Jason Layton

Jason Layton

Director
Patti-Ann Dresback

Patti-Ann Dresback

Director of Operations
Zach Hungate

Zach Hungate

Vice President
Reid Petersen

Reid Petersen

Vice President
Andrew Barry

Andrew Barry

Associate
Stefanie Hilton

Stefanie Hilton

Associate
Frank Perilli

Frank Perilli

Associate
Jay Sojdehei

Jay Sojdehei

Associate
Camden Anderson

Camden Anderson

Analyst
Nic Gianelli

Nic Gianelli

Analyst
Ryan Silvester

Ryan Silvester

Analyst
Jamie Keithahn

Jamie Keithahn

Associate
Michael Levin

Michael Levin

Associate
Zach Zientarski

Zach Zientarski

Analyst
Ray Lens

Ray Lens

Research Analyst
Meet Our Experts